Search
Asymptomatic or subclinical SARS-CoV-2 infections are often unreported, which means that confirmed case counts may not accurately reflect underlying epidemic dynamics. Understanding the level of ascertainment (the ratio of confirmed symptomatic cases to the true number of symptomatic individuals) and undetected epidemic progression is crucial to informing COVID-19 response planning, including the introduction and relaxation of control measures.
As of 1 May 2020, there had been 6808 confirmed cases of COVID-19 in Australia. Of these, 98 had died from the disease. The epidemic had been in decline since mid-March, with 308 cases confirmed nationally since 14 April.
New research highlights the long-term physical health problems faced by people who survive drug-resistant tuberculosis (TB) .
Sophisticated modelling produced is predicting a steady decline in COVID-19 cases in WA throughout August, but hospitalisation rates will remain relatively high.
Honorary Research Associate
Adam Punam Susan Tolu Saddler Amratia Rumisha Okitika PhD PhD PhD (Biostatistics) EMBA, GAICD, PMP, MPH, BSc Senior Research Officer Honorary
Punam Susan Tasmin Amratia Rumisha Symons PhD PhD (Biostatistics) Honorary Research Associate Honorary Research Associate Honorary Research Associate
Punam Susan Tasmin Amratia Rumisha Symons PhD PhD (Biostatistics) Honorary Research Associate Honorary Research Associate Honorary Research Associate
Researchers have developed a new model for simulating covid-19 outbreaks in Western Australia.
Environmental exposure to phthalates and bisphenol A (BPA), chemicals used in the production of plastics, may increase risk for asthma and allergies. However, little is known about the long-term effects of early life exposure to these compounds.